Credit: Shutterstock photoiRadimed, which makes non-magnetic MRI-safe IV infusion pumps, raised $13 million by offering 2.0 million shares at $6.25, above the $5 to $6 range. iRadimed will list on the NASDAQ under the symbol IRMD. Roth Capital acted as sole bookrunner on the deal.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
